Tat-NR2B9c TFA structure
|
Common Name | Tat-NR2B9c TFA | ||
|---|---|---|---|---|
| CAS Number | 1834571-04-8 | Molecular Weight | 2632.90 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C107H189F3N42O32 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Tat-NR2B9c TFATat-NR2B9c (TFA) is a 20-aa peptide, which acts as a postsynaptic density-95 (PSD-95) inhibitor, with an EC50 of 6.7 nM for PSD-95d2 (PSD-95 PDZ domain 2), and 670 nM for PSD-95d1[1]. Tat-NR2B9c also reduces NMDA-induced p38 activation, and possesses neuroprotective efficacy[2]. |
| Name | Tat-NR2B9c TFA |
|---|
| Description | Tat-NR2B9c (TFA) is a 20-aa peptide, which acts as a postsynaptic density-95 (PSD-95) inhibitor, with an EC50 of 6.7 nM for PSD-95d2 (PSD-95 PDZ domain 2), and 670 nM for PSD-95d1[1]. Tat-NR2B9c also reduces NMDA-induced p38 activation, and possesses neuroprotective efficacy[2]. |
|---|---|
| Related Catalog | |
| Target |
EC50: 6.7 nM (PSD-95d2), 670 nM (PSD-95d1)[1] p38[2] |
| References |
| Molecular Formula | C107H189F3N42O32 |
|---|---|
| Molecular Weight | 2632.90 |
| InChIKey | ZTLUQAFFPNSALN-OFWLNFCRSA-N |
| SMILES | CCC(C)C(NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C(N)Cc1ccc(O)cc1)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(C(=O)O)C(C)C.O=C(O)C(F)(F)F |
| Storage condition | 2-8℃ |